Estrace Vaginal Cream Treatment for Vaginal Dryness

Initial Treatment and Efficacy

The National Comprehensive Cancer Network recommends applying 1g of Estrace vaginal cream (containing 0.625mg estradiol) intravaginally daily for the first 2 weeks, followed by twice-weekly maintenance applications for vaginal dryness treatment 1, 2, 3
Treatment addresses multiple symptoms including vaginal dryness, itching, discomfort, and painful intercourse, with significant improvement typically occurring within 4-8 weeks 1, 2, 3
Clinical studies show 80-90% of patients experience symptom relief with proper usage 4

The Centers for Disease Control and Prevention recommends that oil-based creams may weaken latex condoms and diaphragms; patients should check product labeling 4
For women with a history of estrogen-dependent cancers, safety has not been firmly established; consider non-hormonal alternatives first 1, 2, 3
A large cohort study showed no evidence of increased breast cancer-specific mortality in those using vaginal estrogen 1, 2
Vaginal DHEA (prasterone) may be considered for vaginal dryness or pain with sexual activity 1, 2
Ospemifene (a selective estrogen receptor modulator) is FDA-approved for dyspareunia in women without a history of estrogen-dependent cancers 1, 2, 3
Pelvic floor muscle training may improve sexual pain, arousal, lubrication, and satisfaction 3, 5

Patients should be aware of potential drug interactions with other medications 4